Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Sanne C Veltkamp"'
Autor:
Daitlin Esmee Huisman, MD, Erik Wouter Ingwersen, MD, Joanna Luttikhold, MD, PhD, Gerrit Dirk Slooter, MD, PhD, Geert Kazemier, MD, PhD, Freek Daams, MD, PhD, LekCheck Study Group, Audrey Jongen, Carlo V. Feo, Simone Targa, Hidde M. Kroon, Emmanuel A. G. L. Lagae, Aalbert K. Talsma, Johannes A. Wegdam, Bob van Wely, Dirk J. A. Sonneveld, Sanne C. Veltkamp, Emiel G. G. Verdaasdonk, Rudi M. H. Roumen, Freek Daams
Publikováno v:
Annals of Surgery Open, Vol 5, Iss 3, p e478 (2024)
Objective:. The primary objective of this study was to develop a length of stay (LOS) prediction model. Background:. Predicting the LOS is crucial for patient care, planning, managing expectations, and optimizing hospital resources. Prolonged LOS aft
Externí odkaz:
https://doaj.org/article/7fe992fd2bed40bf9e1a7ebff1af2f15
Autor:
Sonja B. Vliek, Florentine S. Hilbers, Agnes Jager, Valesca P. Retèl, Jolien M. Bueno de Mesquita, Caroline A. Drukker, Sanne C. Veltkamp, Anneke M. Zeillemaker, Emiel J. Rutgers, Harm van Tinteren, Wim H. van Harten, Laura J. van 't Veer, Marc J. van de Vijver, Sabine C. Linn
Publikováno v:
European Journal of Cancer, 175, 169-179. Elsevier Limited
European Journal of Cancer, 175, 169-179. Elsevier Ltd.
European journal of cancer, 175, 169-179. Elsevier
European Journal of Cancer, 175, 169-179. Elsevier Ltd.
European journal of cancer, 175, 169-179. Elsevier
Introduction: Prognostic gene expression signatures can be used in combination with classical clinicopathological factors to guide adjuvant chemotherapy decisions in ER-positive, HER2-negative breast cancer. However, long-term outcome data after intr
Autor:
Audrey Jongen, Carlo V. Feo, Stefanus J. van Rooijen, Jurre Stens, Tammo S. de Vries Reilingh, Aalbert K Talsma, Muriël Reudink, Emmanuel A G L Lagae, F. Daams, Simone Targa, Bob van Wely, Wim Bleeker, Boukje T Bootsma, Marie J van Hoogstraten, Laurents P. S. Stassen, Tarik Sammour, Rudi M. H. Roumen, D. J. A. Sonneveld, Gerrit D. Slooter, Niels Komen, Tim van de Brug, Hidde M. Kroon, Johannes A. Wegdam, Daitlin E Huisman, Sanne C Veltkamp, Emiel G. G. Verdaasdonk
Publikováno v:
Annals of Surgery, 275(1), E189-E197. LIPPINCOTT WILLIAMS & WILKINS
Huisman, D E, Reudink, M, van Rooijen, S J, Bootsma, B T, van de Brug, T, Stens, J, Bleeker, W, Stassen, L P S, Jongen, A, Feo, C V, Targa, S, Komen, N, Kroon, H M, Sammour, T, Lagae, E A G L, Talsma, A K, Wegdam, J A, de Vries Reilingh, T S, van Wely, B, van Hoogstraten, M J, Sonneveld, D J A, Veltkamp, S C, Verdaasdonk, E G G, Roumen, R M H, Slooter, G D & Daams, F 2022, ' LekCheck : A Prospective Study to Identify Perioperative Modifiable Risk Factors for Anastomotic Leakage in Colorectal Surgery ', Annals of Surgery, vol. 275, no. 1, pp. E189-E197 . https://doi.org/10.1097/SLA.0000000000003853
Annals of Surgery, 275(1), E189-E197. Lippincott Williams and Wilkins
Annals of Surgery
Annals of surgery
Huisman, D E, Reudink, M, van Rooijen, S J, Bootsma, B T, van de Brug, T, Stens, J, Bleeker, W, Stassen, L P S, Jongen, A, Feo, C V, Targa, S, Komen, N, Kroon, H M, Sammour, T, Lagae, E A G L, Talsma, A K, Wegdam, J A, de Vries Reilingh, T S, van Wely, B, van Hoogstraten, M J, Sonneveld, D J A, Veltkamp, S C, Verdaasdonk, E G G, Roumen, R M H, Slooter, G D & Daams, F 2022, ' LekCheck : A Prospective Study to Identify Perioperative Modifiable Risk Factors for Anastomotic Leakage in Colorectal Surgery ', Annals of Surgery, vol. 275, no. 1, pp. E189-E197 . https://doi.org/10.1097/SLA.0000000000003853
Annals of Surgery, 275(1), E189-E197. Lippincott Williams and Wilkins
Annals of Surgery
Annals of surgery
Objective: To assess potentially modifiable perioperative risk factors for anastomotic leakage in adult patients undergoing colorectal surgery. Summary Background Data: Colorectal anastomotic leakage (CAL) is the single most important denominator of
Autor:
Marc J. van de Vijver, Harry Bartelink, Dimitry S.A. Nuyten, Sanne C. Veltkamp, John A. Foekens, Peter Bult, Nicola Armstrong, Hans Halfwerk, Bas Kreike
Supplementary Data from Local Recurrence after Breast-Conserving Therapy in Relation to Gene Expression Patterns in a Large Series of Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a68d6b59f6020db72a21eeefe011f829
https://doi.org/10.1158/1078-0432.22440322.v1
https://doi.org/10.1158/1078-0432.22440322.v1
Autor:
Marc J. van de Vijver, Harry Bartelink, Dimitry S.A. Nuyten, Sanne C. Veltkamp, John A. Foekens, Peter Bult, Nicola Armstrong, Hans Halfwerk, Bas Kreike
Purpose: The majority of patients with early-stage breast cancer are treated with breast-conserving therapy (BCT). Several clinical risk factors are associated with local recurrence (LR) after BCT but are unable to explain all instances of LR after B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23ee739e6b2088a2e94445cbaa70ac76
https://doi.org/10.1158/1078-0432.c.6517669.v1
https://doi.org/10.1158/1078-0432.c.6517669.v1
Autor:
Sanne A.L. Bartels, Mila Donker, Coralie Poncet, Nicolas Sauvé, Marieke E. Straver, Cornelis J.H. van de Velde, Robert E. Mansel, Charlotte Blanken, Lorenzo Orzalesi, Jean H.G. Klinkenbijl, Huub C.J. van der Mijle, Grard A.P. Nieuwenhuijzen, Sanne C. Veltkamp, Thijs van Dalen, Andreas Marinelli, Herman Rijna, Marko Snoj, Nigel J. Bundred, Jos W.S. Merkus, Yazid Belkacemi, Patrick Petignat, Dominic A.X. Schinagl, Corneel Coens, Geertjan van Tienhoven, Frederieke van Duijnhoven, Emiel J.T. Rutgers
Publikováno v:
Journal of Clinical Oncology, 41, 12, pp. 2159-2165
Bartels, S A L, Donker, M, Poncet, C, Sauvé, N, Straver, M E, van de Velde, C J H, Mansel, R E, Blanken, C, Orzalesi, L, Klinkenbijl, J H G, van der Mijle, H C J, Nieuwenhuijzen, G A P, Veltkamp, S C, van Dalen, T, Marinelli, A, Rijna, H, Snoj, M, Bundred, N J, Merkus, J W S, Belkacemi, Y, Petignat, P, Schinagl, D A X, Coens, C, van Tienhoven, G, van Duijnhoven, F & Rutgers, E J T 2023, ' Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer : 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 41, no. 12, pp. 2159-2165 . https://doi.org/10.1200/JCO.22.01565
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(12), 2159-2165. American Society of Clinical Oncology
Journal of Clinical Oncology, 41, 2159-2165
Journal of clinical oncology, 41(12), 2159-2165. American Society of Clinical Oncology
Bartels, S A L, Donker, M, Poncet, C, Sauvé, N, Straver, M E, van de Velde, C J H, Mansel, R E, Blanken, C, Orzalesi, L, Klinkenbijl, J H G, van der Mijle, H C J, Nieuwenhuijzen, G A P, Veltkamp, S C, van Dalen, T, Marinelli, A, Rijna, H, Snoj, M, Bundred, N J, Merkus, J W S, Belkacemi, Y, Petignat, P, Schinagl, D A X, Coens, C, van Tienhoven, G, van Duijnhoven, F & Rutgers, E J T 2023, ' Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer : 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 41, no. 12, pp. 2159-2165 . https://doi.org/10.1200/JCO.22.01565
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(12), 2159-2165. American Society of Clinical Oncology
Journal of Clinical Oncology, 41, 2159-2165
Journal of clinical oncology, 41(12), 2159-2165. American Society of Clinical Oncology
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b35094e58c4c415bd41b92262d38d2a3
https://repository.ubn.ru.nl/handle/2066/293134
https://repository.ubn.ru.nl/handle/2066/293134
Autor:
Ignace H. J. T. de Hingh, Erwin van der Harst, Victor J. Verwaal, Edwin S. van der Zaag, Karlijn van Woensdregt, R.T.J. Kortekaas, Bas Inberg, Sebastiaan Festen, Petur Snaebjornsson, Karin K. van Diepen, Anna A. W. van Geloven, Alexandra Brandt, Roderick F. Schmitz, Pieter J. Tanis, Koen C.M.J. Peeters, Cornelis J. A. Punt, Eva V. E. Madsen, Sanne C. Veltkamp, Charlotte E. L. Klaver, Johanne Bloemen, P.A. Neijenhuis, Eino B. van Duyn, Thomas J.M. Kootstra, Henderik L van Westreenen, Johannes H. W. de Wilt, T.C. van Sprundel, Emma C. E. Wassenaar, M. Westerterp, Philip R. de Reuver, Jennifer Demelinne, Dirkje W. Sommeijer, Loes van den Nieuwenhof, Marinus J. Wiezer, H.C.J. van der Mijle, Pauline Evers, Rogier M P H Crolla, Annette A van Zweeden, Joost T. Heikens, Daniel A. Hess, Marcel G. W. Dijkgraaf, Jan Jansen, D. J. A. Sonneveld, Anthony W. H. van de Ven, Frank W.H. Kloppenberg, Mandy Zournas, Patrick H. J. Hemmer, Koen P. Rovers, J. W. T. Dekker, Daniel D Wisselink, Jacobus W. A. Burger, Huib A. Cense, Esther D. van den Ende, David D. E. Zimmerman, Wilhelmina M U van Grevenstein, Frank C. den Boer, Jarmila D. W. van der Bilt, Sandra A Radema, Vivian P. Bastiaenen, Djamila Boerma, Johannes Crezee, Maarten Vermaas, Hans F. J. Fabry, Maartje Los, Floris Ferenschild, Lotte Schoonderwoerd, Walter J.A. Brokelman, Jeroen Heemskerk, Pieter Poortman, Jurriaan B. Tuynman, Johannes A. Wegdam, Marc J. van Det, Linda Mol, Bert van Ramshorst, Arend G. J. Aalbers, Marjolein Diepeveen, Gijsbert D. Musters, Arjen J. Witkamp, Daan ten Bokkel Huinink, Niels F. M. Kok, Simon W. Nienhuijs, Willem A. Bemelman, Geert-Jan Creemers, Jolien Pon, Caroline S. Andeweg, Sebastiaan W. Polle, Esther C. J. Consten, Nina R. Sluiter, Fennie Wit, A.J.A. Bremers
Publikováno v:
Lancet Gastroenterology & Hepatology, 4, 761-770
Lancet Gastroenterology & Hepatology, 4, 10, pp. 761-770
Klaver, C E L, Wisselink, D D, Punt, C J A, Snaebjornsson, P, Crezee, J, Aalbers, A G J, Brandt, A, Bremers, A J A, Burger, J W A, Fabry, H F J, Ferenschild, F, Festen, S, van Grevenstein, W M U, Hemmer, P H J, de Hingh, I H J T, Kok, N F M, Musters, G D, Schoonderwoerd, L, Tuynman, J B, van de Ven, A W H, van Westreenen, H L, Wiezer, M J, Zimmerman, D D E, van Zweeden, A A, Dijkgraaf, M G W, Tanis, P J & COLOPEC collaborators group 2019, ' Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC) : a multicentre, open-label, randomised trial ', The Lancet. Gastroenterology & hepatology, vol. 4, no. 10, pp. 761-770 . https://doi.org/10.1016/S2468-1253(19)30239-0
Klaver, C E L, Wisselink, D D, Punt, C J A, Snaebjornsson, P, Crezee, J, Aalbers, A G J, Brandt, A, Bremers, A J A, Burger, J W A, Fabry, H F J, Ferenschild, F, Festen, S, van Grevenstein, W M U, Hemmer, P H J, de Hingh, I H J T, Kok, N F M, Musters, G D, Schoonderwoerd, L, Tuynman, J B, van de Ven, A W H, van Westreenen, H L, Wiezer, M J, Zimmerman, D D E, van Zweeden, A A, Dijkgraaf, M G W, Tanis, P J & COLOPEC collaborators group 2019, ' Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial ', The Lancet Gastroenterology and Hepatology, vol. 4, no. 10, pp. 761-770 . https://doi.org/10.1016/S2468-1253(19)30239-0
The Lancet Gastroenterology and Hepatology, 4(10), 761-770. Elsevier Ltd
The Lancet Gastroenterology and Hepatology, 4(10), 761. Elsevier Limited
Lancet Gastroenterology & Hepatology, 4(10), 761-770. Elsevier Ltd.
Klaver, C E L, Wisselink, D D, Punt, C J A, Snaebjornsson, P, Crezee, J, Aalbers, A G J, Brandt, A, Bremers, A J A, Burger, J W A, Fabry, H F J, Ferenschild, F, Festen, S, van Grevenstein, W M U, Hemmer, P H J, de Hingh, I H J T, Kok, N F M, Musters, G D, Schoonderwoerd, L, Tuynman, J B, van de Ven, A W H, van Westreenen, H L, Wiezer, M J, Zimmerman, D D E, van Zweeden, A A, Dijkgraaf, M G W, Tanis, P J, COLOPEC collaborators group & Jilbert Verwaal, V 2019, ' Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC) : a multicentre, open-label, randomised trial ', The Lancet Gastroenterology & Hepatology, vol. 4, no. 10, pp. 761-770 . https://doi.org/10.1016/S2468-1253(19)30239-0
Lancet gastroenterology & hepatology, 4(10), 761-770. HANLEY & BELFUS-ELSEVIER INC
lancet. Gastroenterology & hepatology, 4(10), 761-770. Elsevier Limited
Lancet Gastroenterology & Hepatology, 4, 10, pp. 761-770
Klaver, C E L, Wisselink, D D, Punt, C J A, Snaebjornsson, P, Crezee, J, Aalbers, A G J, Brandt, A, Bremers, A J A, Burger, J W A, Fabry, H F J, Ferenschild, F, Festen, S, van Grevenstein, W M U, Hemmer, P H J, de Hingh, I H J T, Kok, N F M, Musters, G D, Schoonderwoerd, L, Tuynman, J B, van de Ven, A W H, van Westreenen, H L, Wiezer, M J, Zimmerman, D D E, van Zweeden, A A, Dijkgraaf, M G W, Tanis, P J & COLOPEC collaborators group 2019, ' Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC) : a multicentre, open-label, randomised trial ', The Lancet. Gastroenterology & hepatology, vol. 4, no. 10, pp. 761-770 . https://doi.org/10.1016/S2468-1253(19)30239-0
Klaver, C E L, Wisselink, D D, Punt, C J A, Snaebjornsson, P, Crezee, J, Aalbers, A G J, Brandt, A, Bremers, A J A, Burger, J W A, Fabry, H F J, Ferenschild, F, Festen, S, van Grevenstein, W M U, Hemmer, P H J, de Hingh, I H J T, Kok, N F M, Musters, G D, Schoonderwoerd, L, Tuynman, J B, van de Ven, A W H, van Westreenen, H L, Wiezer, M J, Zimmerman, D D E, van Zweeden, A A, Dijkgraaf, M G W, Tanis, P J & COLOPEC collaborators group 2019, ' Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial ', The Lancet Gastroenterology and Hepatology, vol. 4, no. 10, pp. 761-770 . https://doi.org/10.1016/S2468-1253(19)30239-0
The Lancet Gastroenterology and Hepatology, 4(10), 761-770. Elsevier Ltd
The Lancet Gastroenterology and Hepatology, 4(10), 761. Elsevier Limited
Lancet Gastroenterology & Hepatology, 4(10), 761-770. Elsevier Ltd.
Klaver, C E L, Wisselink, D D, Punt, C J A, Snaebjornsson, P, Crezee, J, Aalbers, A G J, Brandt, A, Bremers, A J A, Burger, J W A, Fabry, H F J, Ferenschild, F, Festen, S, van Grevenstein, W M U, Hemmer, P H J, de Hingh, I H J T, Kok, N F M, Musters, G D, Schoonderwoerd, L, Tuynman, J B, van de Ven, A W H, van Westreenen, H L, Wiezer, M J, Zimmerman, D D E, van Zweeden, A A, Dijkgraaf, M G W, Tanis, P J, COLOPEC collaborators group & Jilbert Verwaal, V 2019, ' Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC) : a multicentre, open-label, randomised trial ', The Lancet Gastroenterology & Hepatology, vol. 4, no. 10, pp. 761-770 . https://doi.org/10.1016/S2468-1253(19)30239-0
Lancet gastroenterology & hepatology, 4(10), 761-770. HANLEY & BELFUS-ELSEVIER INC
lancet. Gastroenterology & hepatology, 4(10), 761-770. Elsevier Limited
BACKGROUND: Nearly a quarter of patients with locally advanced (T4 stage) or perforated colon cancer are at risk of developing peritoneal metastases, often without curative treatment options. We aimed to determine the efficacy of adjuvant hyperthermi
Autor:
Yazid Belkacemi, Dominic A.X. Schinagl, Herman Rijna, A. Marinelli, Jean H. G. Klinkenbijl, Grard A. P. Nieuwenhuijzen, Jos W. S. Merkus, Carlo Messina, Marko Snoj, Marieke E. Straver, Willem H. Bouma, Nigel J Bundred, Thijs van Dalen, A. Helen Westenberg, Huub van der Mijle, Nicole Duez, P. Meijnen, Emiel J. Th. Rutgers, Patrick Petignat, Corneel Coens, Robert E. Mansel, Leen Slaets, Lorenzo Orzalesi, Sanne C. Veltkamp, Jan Bogaerts, Luigi Cataliotti, Peter W. de Graaf, Geertjan van Tienhoven, Cornelis J.H. van de Velde, M. Donker
Publikováno v:
Lancet Oncology, 15, 1303-10
Lancet Oncology, 15, 12, pp. 1303-10
The Lancet Oncology, 15(12), 1303-1310
The Lancet Oncology, Vol. 15, No 12 (2014) pp. 1303-1310
lancet oncology, 15(12), 1303-1310. Lancet Publishing Group
Lancet Oncology, 15, 12, pp. 1303-10
The Lancet Oncology, 15(12), 1303-1310
The Lancet Oncology, Vol. 15, No 12 (2014) pp. 1303-1310
lancet oncology, 15(12), 1303-1310. Lancet Publishing Group
Item does not contain fulltext BACKGROUND: If treatment of the axilla is indicated in patients with breast cancer who have a positive sentinel node, axillary lymph node dissection is the present standard. Although axillary lymph node dissection provi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53caae6015ff98251c49c7a028271756
http://hdl.handle.net/2066/139222
http://hdl.handle.net/2066/139222
Autor:
Huub van der Mijle, Grard A. P. Nieuwenhuijzen, Willem H. Bouma, Cornelis J.H. van de Velde, Emiel J. Th. Rutgers, Lorenzo Orzalesi, A. Helen Westenberg, Saskia Litière, Nicole Duez, Marieke E. Straver, M. Donker, Robert E. Mansel, Geertjan van Tienhoven, Sanne C. Veltkamp, G. Werutsky
Publikováno v:
European Journal of Cancer, 49(9), 2093-2100
Introduction Multifocal breast cancer is associated with a higher risk of nodal involvement compared to unifocal breast cancer and the drainage pattern from multifocal localisations may be different. For this reason, the value of the sentinel node bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c7bfbe5905c4228c4eda6d437e36e6b
https://hdl.handle.net/1887/102120
https://hdl.handle.net/1887/102120
Autor:
Cornelis J.H. van de Velde, Grard A. P. Nieuwenhuijzen, Helen A. Westenberg, M. Donker, Marieke E. Straver, Robert E. Mansel, Lorenzo Orzalesi, Willem H. Bouma, Nicole Duez, Coen W. Hurkmans, Leen Slaets, Huub van der Mijle, Geertjan van Tienhoven, Sanne C. Veltkamp, Jan Bogaerts, Carlo Messina, Emiel J. Th. Rutgers, P. Meijnen
Publikováno v:
Journal of Clinical Oncology. 31:LBA1001-LBA1001
LBA1001 Background: Sentinel node biopsy (SNB) is standard in assessing axillary lymph node status for cN0 breast cancer patients. In case of a positive SNB, if treatment is advised, axillary lymph node dissection (ALND) is the current standard. Alth